{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:03:51Z","timestamp":1780308231690,"version":"3.54.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K07577"],"award-info":[{"award-number":["19K07577"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science,Japan","doi-asserted-by":"crossref","award":["24K10232"],"award-info":[{"award-number":["24K10232"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Next-Generation Research Support Program, Tottori University","award":["FY2024\u20132025"],"award-info":[{"award-number":["FY2024\u20132025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11262-026-02238-7","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:55:34Z","timestamp":1776074134000},"page":"370-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ibudilast and dipyridamole ameliorate murine \u03b3-herpesvirus 68-induced acute hepatitis following airway infection"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4871-4259","authenticated-orcid":false,"given":"Koyuki Atifa","family":"Rahmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9202-2666","authenticated-orcid":false,"given":"Hisashi","family":"Iizasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7588-278X","authenticated-orcid":false,"given":"Hironori","family":"Yoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-3567","authenticated-orcid":false,"given":"Yusuke","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5220-6137","authenticated-orcid":false,"given":"Seiji","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7984-207X","authenticated-orcid":false,"given":"Kyosuke","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"2238_CR1","volume-title":"Human herpesviruses: biology, therapy, and immunoprophylaxis","author":"R Longnecker","year":"2007","unstructured":"Longnecker R, Neipel F et al (2007) Introduction to the human gamma-herpesviruses. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R (eds) Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge"},{"issue":"7","key":"2238_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343(7):481\u2013492. https:\/\/doi.org\/10.1056\/NEJM200008173430707","journal-title":"N Engl J Med"},{"issue":"21","key":"2238_CR3","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","volume":"362","author":"K Luzuriaga","year":"2010","unstructured":"Luzuriaga K, Sullivan JL (2010) Infectious mononucleosis. N Engl J Med 362(21):1993\u20132000. https:\/\/doi.org\/10.1056\/NEJMcp1001116","journal-title":"N Engl J Med"},{"issue":"2","key":"2238_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1442-200x.1997.tb03575.x","volume":"39","author":"H Kanegane","year":"1997","unstructured":"Kanegane H, Kanegane C, Yachie A, Miyawaki T, Tosato G (1997) Infectious mononucleosis as a disease of early childhood in Japan caused by primary Epstein-Barr virus infection. Acta Paediatr Jpn 39(2):166\u2013171. https:\/\/doi.org\/10.1111\/j.1442-200x.1997.tb03575.x","journal-title":"Acta Paediatr Jpn"},{"issue":"1","key":"2238_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.virusres.2010.07.026","volume":"153","author":"K Kanai","year":"2010","unstructured":"Kanai K, Takashima K, Okuno K, Kato K, Sano H, Kuwamoto S et al (2010) Lifelong persistent EBV infection of rabbits with EBER1-positive lymphocyte infiltration and mild sublethal hemophagocytosis. Virus Res 153(1):172\u2013178. https:\/\/doi.org\/10.1016\/j.virusres.2010.07.026","journal-title":"Virus Res"},{"key":"2238_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9020116","author":"S Fujiwara","year":"2020","unstructured":"Fujiwara S, Nakamura H (2020) Animal models for gammaherpesvirus infections: recent development in the analysis of virus-induced pathogenesis. Pathogens. https:\/\/doi.org\/10.3390\/pathogens9020116","journal-title":"Pathogens"},{"issue":"2","key":"2238_CR7","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.4049\/jimmunol.165.2.1074","volume":"165","author":"E Flano","year":"2000","unstructured":"Flano E, Husain SM, Sample JT, Woodland DL, Blackman MA (2000) Latent Murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol 165(2):1074\u20131081. https:\/\/doi.org\/10.4049\/jimmunol.165.2.1074","journal-title":"J Immunol"},{"issue":"10","key":"2238_CR8","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.4049\/jimmunol.2200653","volume":"211","author":"K Kanai","year":"2023","unstructured":"Kanai K, Kageyama S, Yoshie O (2023) Involvement of TLR4 in acute hepatitis associated with airway infection of Murine \u03b3-Herpesvirus 68. J Immunol 211(10):1550\u20131560. https:\/\/doi.org\/10.4049\/jimmunol.2200653","journal-title":"J Immunol"},{"issue":"7","key":"2238_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1053\/hupa.2001.25597","volume":"32","author":"H Kimura","year":"2001","unstructured":"Kimura H, Nagasaka T, Hoshino Y, Hayashi N, Tanaka N, Xu JL et al (2001) Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes. Hum Pathol 32(7):757\u2013762. https:\/\/doi.org\/10.1053\/hupa.2001.25597","journal-title":"Hum Pathol"},{"issue":"8","key":"2238_CR10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1248\/bpb.b22-00284","volume":"45","author":"N Kadota","year":"2022","unstructured":"Kadota N, Yoshida A, Sawamoto A, Okuyama S, Nakajima M (2022) Ibudilast reduces IL-6 levels and ameliorates symptoms in lipopolysaccharide-induced sepsis mice. Biol Pharm Bull 45(8):1180\u20131184. https:\/\/doi.org\/10.1248\/bpb.b22-00284","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"2238_CR11","doi-asserted-by":"publisher","first-page":"e18633","DOI":"10.1371\/journal.pone.0018633","volume":"6","author":"M Kiebala","year":"2011","unstructured":"Kiebala M, Maggirwar SB (2011) Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells. PLoS ONE 6(4):e18633. https:\/\/doi.org\/10.1371\/journal.pone.0018633","journal-title":"PLoS ONE"},{"issue":"10","key":"2238_CR12","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1080\/13543784.2016.1221924","volume":"25","author":"AD Goodman","year":"2016","unstructured":"Goodman AD, Gyang T, Smith AD 3rd (2016) Ibudilast for the treatment of multiple sclerosis. Expert Opin Investig Drugs 25(10):1231\u20137. https:\/\/doi.org\/10.1080\/13543784.2016.1221924","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"2238_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1089\/adt.2015.29017.patdrrr","volume":"13","author":"HAM Mucke","year":"2015","unstructured":"Mucke HAM (2015) Drug repurposing patent applications January-March 2015. Assay Drug Dev Technol 13(6):332\u2013337. https:\/\/doi.org\/10.1089\/adt.2015.29017.patdrrr","journal-title":"Assay Drug Dev Technol"},{"issue":"6","key":"2238_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.2174\/1381612826666201001125604","volume":"27","author":"KF Aliter","year":"2021","unstructured":"Aliter KF, Al-Horani RA (2021) Potential therapeutic benefits of dipyridamole in COVID-19 patients. Curr Pharm Des 27(6):866\u2013875. https:\/\/doi.org\/10.2174\/1381612826666201001125604","journal-title":"Curr Pharm Des"},{"key":"2238_CR15","doi-asserted-by":"publisher","first-page":"104615","DOI":"10.1016\/j.antiviral.2019.104615","volume":"172","author":"MP Thome","year":"2019","unstructured":"Thome MP, Borde C, Larsen AK, Henriques JAP, Lenz G, Escargueil AE et al (2019) Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation. Antivir Res 172:104615. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104615","journal-title":"Antivir Res"},{"issue":"3","key":"2238_CR16","doi-asserted-by":"publisher","first-page":"s39","DOI":"10.1161\/ATVBAHA.107.160226","volume":"28","author":"HH Kim","year":"2008","unstructured":"Kim HH, Liao JK (2008) Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol 28(3):s39-42. https:\/\/doi.org\/10.1161\/ATVBAHA.107.160226","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2238_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10557-021-07224-9","volume":"36","author":"M Allahham","year":"2022","unstructured":"Allahham M, Lerman A, Atar D, Birnbaum Y (2022) Why not dipyridamole: a review of current guidelines and re-evaluation of utility in the modern era. Cardiovasc Drugs Ther 36(3):525\u2013532. https:\/\/doi.org\/10.1007\/s10557-021-07224-9","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"2238_CR18","doi-asserted-by":"publisher","first-page":"E262","DOI":"10.1210\/jc.2014-2886","volume":"100","author":"L Fang","year":"2015","unstructured":"Fang L, Chang HM, Cheng JC, Leung PC, Sun YP (2015) Nitric oxide and cGMP induce COX-2 expression and PGE2 production in human granulosa cells through CREB signaling pathway. J Clin Endocrinol Metab 100(2):E262\u2013E269. https:\/\/doi.org\/10.1210\/jc.2014-2886","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2238_CR19","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.4049\/jimmunol.1700412","volume":"200","author":"K Kanai","year":"2018","unstructured":"Kanai K, Park AM, Watanabe A, Arikawa T, Yasui T, Yoshida H et al (2018) Murine \u03b3-Herpesvirus 68 induces severe lung inflammation in IL-27\u2013deficient mice with liver dysfunction preventable by oral neomycin. J Immunol 200(8):2703\u20132713. https:\/\/doi.org\/10.4049\/jimmunol.1700412","journal-title":"J Immunol"},{"issue":"7","key":"2238_CR20","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M et al (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18(7):e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410","journal-title":"PLoS Biol"},{"issue":"8","key":"2238_CR21","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.1128\/JVI.71.8.5894-5904.1997","volume":"71","author":"HWt Virgin","year":"1997","unstructured":"Virgin HWt, Latreille P, Wamsley P, Hallsworth K, Weck KE, Dal Canto AJ et al (1997) Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71(8):5894\u20135904. https:\/\/doi.org\/10.1128\/JVI.71.8.5894-5904.1997","journal-title":"J Virol"},{"issue":"10","key":"2238_CR22","doi-asserted-by":"publisher","first-page":"6775","DOI":"10.1128\/JVI.70.10.6775-6780.1996","volume":"70","author":"KE Weck","year":"1996","unstructured":"Weck KE, Barkon ML, Yoo LI, Speck SH, Virgin HI (1996) Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J Virol 70(10):6775\u20136780. https:\/\/doi.org\/10.1128\/JVI.70.10.6775-6780.1996","journal-title":"J Virol"},{"issue":"5","key":"2238_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1538\/expanim.60.481","volume":"60","author":"S Kawai","year":"2011","unstructured":"Kawai S, Takagi Y, Kaneko S, Kurosawa T (2011) Effect of three types of mixed anesthetic agents alternate to ketamine in mice. Exp Anim 60(5):481\u2013487. https:\/\/doi.org\/10.1538\/expanim.60.481","journal-title":"Exp Anim"},{"issue":"4","key":"2238_CR24","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2353\/ajpath.2006.051296","volume":"168","author":"DH Adams","year":"2006","unstructured":"Adams DH, Hubscher SG (2006) Systemic viral infections and collateral damage in the liver. Am J Pathol 168(4):1057\u20131059. https:\/\/doi.org\/10.2353\/ajpath.2006.051296","journal-title":"Am J Pathol"},{"issue":"12","key":"2238_CR25","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1080\/00365521.2024.2422947","volume":"59","author":"L Bathobakae","year":"2024","unstructured":"Bathobakae L, Bashir R, Wilkinson T, Phuu P, Koodirile A, Yuridullah R et al (2024) Non-hepatotropic viral hepatitis: a narrative review. Scand J Gastroenterol 59(12):1322\u20131329. https:\/\/doi.org\/10.1080\/00365521.2024.2422947","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"2238_CR26","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","volume":"36","author":"A Zlotnik","year":"2012","unstructured":"Zlotnik A, Yoshie O (2012) The chemokine superfamily revisited. Immunity 36(5):705\u2013716. https:\/\/doi.org\/10.1016\/j.immuni.2012.05.008","journal-title":"Immunity"},{"issue":"2","key":"2238_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/icb.2010.158","volume":"89","author":"JR Groom","year":"2011","unstructured":"Groom JR, Luster AD (2011) CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89(2):207\u2013215. https:\/\/doi.org\/10.1038\/icb.2010.158","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"2238_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-022-01058-z","volume":"7","author":"GH Ran","year":"2022","unstructured":"Ran GH, Lin YQ, Tian L, Zhang T, Yan DM, Yu JH et al (2022) Natural killer cell homing and trafficking in tissues and tumors: from biology to application. Signal Transduct Target Ther 7(1):205. https:\/\/doi.org\/10.1038\/s41392-022-01058-z","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2238_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jcv.2005.07.009","volume":"35","author":"S Hara","year":"2006","unstructured":"Hara S, Hoshino Y, Naitou T, Nagano K, Iwai M, Suzuki K et al (2006) Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection. J Clin Virol 35(3):250\u2013256. https:\/\/doi.org\/10.1016\/j.jcv.2005.07.009","journal-title":"J Clin Virol"},{"key":"2238_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27238448","author":"E Angelopoulou","year":"2022","unstructured":"Angelopoulou E, Pyrgelis ES, Piperi C (2022) Emerging potential of the phosphodiesterase (PDE) inhibitor Ibudilast for neurodegenerative diseases: an update on preclinical and clinical evidence. Molecules. https:\/\/doi.org\/10.3390\/molecules27238448","journal-title":"Molecules"},{"issue":"10","key":"2238_CR31","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/QAD.0000000000000291","volume":"28","author":"N El-Hage","year":"2014","unstructured":"El-Hage N, Rodriguez M, Podhaizer EM, Zou S, Dever SM, Snider SE et al (2014) Ibudilast (AV411], and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphine. AIDS 28(10):1409\u20131419. https:\/\/doi.org\/10.1097\/QAD.0000000000000291","journal-title":"AIDS"},{"key":"2238_CR32","doi-asserted-by":"publisher","first-page":"1567226","DOI":"10.3389\/fnmol.2025.1567226","volume":"18","author":"KA Alyami","year":"2025","unstructured":"Alyami KA, Alshahrany GA, Al-Otaibi KM, Alam MZ, Alghamdi BS, Alsufiani HM et al (2025) Potential therapeutic effects of ibudilast and retinoic acid against cuprizone-induced behavioral and biochemical changes in mouse brain. Front Mol Neurosci 18:1567226. https:\/\/doi.org\/10.3389\/fnmol.2025.1567226","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2238_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41420-023-01524-9","volume":"9","author":"C Zhou","year":"2023","unstructured":"Zhou C, Gao Y, Ding P, Wu T, Ji G (2023) The role of CXCL family members in different diseases. Cell Death Discov 9(1):212. https:\/\/doi.org\/10.1038\/s41420-023-01524-9","journal-title":"Cell Death Discov"},{"issue":"6","key":"2238_CR34","doi-asserted-by":"publisher","first-page":"R289","DOI":"10.1186\/cc10576","volume":"15","author":"BP Ramakers","year":"2011","unstructured":"Ramakers BP, Riksen NP, Stal TH, Heemskerk S, van den Broek P, Peters WH et al (2011) Dipyridamole augments the antiinflammatory response during human endotoxemia. Crit Care 15(6):R289. https:\/\/doi.org\/10.1186\/cc10576","journal-title":"Crit Care"},{"issue":"17","key":"2238_CR35","doi-asserted-by":"publisher","first-page":"11062","DOI":"10.1128\/JVI.79.17.11062-11070.2005","volume":"79","author":"CL Fata-Hartley","year":"2005","unstructured":"Fata-Hartley CL, Palmenberg AC (2005) Dipyridamole reversibly inhibits mengovirus RNA replication. J Virol 79(17):11062\u201311070. https:\/\/doi.org\/10.1128\/JVI.79.17.11062-11070.2005","journal-title":"J Virol"},{"issue":"12","key":"2238_CR36","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1128\/AAC.45.12.3657-3659.2001","volume":"45","author":"RB Tenser","year":"2001","unstructured":"Tenser RB, Gaydos A, Hay KA (2001) Inhibition of herpes simplex virus reactivation by dipyridamole. Antimicrob Agents Chemother 45(12):3657\u20133659. https:\/\/doi.org\/10.1128\/AAC.45.12.3657-3659.2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2238_CR37","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1093\/jac\/dky161","volume":"73","author":"C Zeippen","year":"2018","unstructured":"Zeippen C, Javaux J, Snoeck R, Neyts J, Gillet L (2018) Antiviral effect of the nucleoside analogue cidofovir in the context of sexual transmission of a gammaherpesvirus in mice. J Antimicrob Chemother 73(8):2095\u20132103. https:\/\/doi.org\/10.1093\/jac\/dky161","journal-title":"J Antimicrob Chemother"},{"issue":"17","key":"2238_CR38","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1517\/14656560903426189","volume":"10","author":"P Rolan","year":"2009","unstructured":"Rolan P, Hutchinson M, Johnson K (2009) Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. Expert Opin Pharmacother 10(17):2897\u20132904. https:\/\/doi.org\/10.1517\/14656560903426189","journal-title":"Expert Opin Pharmacother"},{"key":"2238_CR39","unstructured":"Kerndt CC, Nagalli S. Dipyridamole (2025) Treasure Island (FL) ineligible companies. Disclosure: Shivaraj Nagalli, Declares no relevant financial relationships with ineligible companies. StatPearls, St. Petersburg"},{"issue":"3","key":"2238_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF03189959","volume":"16","author":"G Ricevuti","year":"1991","unstructured":"Ricevuti G, Mazzone A, Pasotti D, Uccelli E, Pasquali F, Gazzani G et al (1991) Pharmacokinetics of dipyridamole-\u03b2-cyclodextrin complex in healthy volunteers after single and multiple doses. Eur J Drug Metab Pharmacokinet 16(3):197\u2013201. https:\/\/doi.org\/10.1007\/BF03189959","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-026-02238-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-026-02238-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-026-02238-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:26:42Z","timestamp":1780306002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-026-02238-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2238"],"URL":"https:\/\/doi.org\/10.1007\/s11262-026-02238-7","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.\n                      Ethical considerations\n                      This study received approval from the Institutional Animal Care and Use Committee of Tottori University (Approval No. 23-Y-1), and all animal procedures adhered to the institution\u2019s guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}